Somatrobol
Overview
Somatrobol British Dragon is a recombinant human growth hormone (rhGH) product containing 191-amino acid somatropin identical in sequence to endogenous pituitary GH. Each kit contains 100 IU of lyophilized powder requiring reconstitution with bacteriostatic water prior to subcutaneous injection. Steroid Warehouse carries the full British Dragon HGH lineup, including Somatrobol for users running extended performance or body recomposition cycles.
About the Compound
Somatrobol contains recombinant somatropin produced via recombinant DNA technology. The 191-amino acid sequence is identical to pituitary-derived human GH and binds to GH receptors in the liver, adipose tissue, muscle, and bone. The primary downstream mediator is insulin-like growth factor-1 (IGF-1), synthesized in the liver upon GH receptor activation. IGF-1 drives the majority of anabolic and lipolytic effects attributed to exogenous GH use.
Reconstitution is performed using bacteriostatic water (0.9% benzyl alcohol). A 10 IU vial typically dissolves in 1–2 mL of bac water. Injections are administered subcutaneously into abdominal fat with site rotation on each use. Reconstituted solution must be refrigerated and used within 28 days; do not freeze.
What It Does
GH receptor activation by Somatrobol triggers a cascade of metabolic and anabolic effects through two primary pathways: direct receptor signaling and IGF-1 mediation.
- Lipolysis: GH directly stimulates hormone-sensitive lipase in adipose tissue, increasing free fatty acid mobilization. This effect is independent of IGF-1 and is most pronounced during fasted or low-insulin states. Visible fat reduction — particularly visceral and subcutaneous — typically develops within 6–12 weeks at doses of 2 IU/day or higher.
- IGF-1 production: Hepatic GH receptor activation drives IGF-1 synthesis. IGF-1 is the primary mediator of muscle protein synthesis, nitrogen retention, satellite cell activation, and connective tissue repair. Serum IGF-1 levels typically rise within 2–4 weeks and serve as the standard dose-calibration biomarker.
- Muscle recovery: Collagen synthesis is enhanced by both GH and IGF-1, accelerating repair of tendons, ligaments, and cartilage. This makes Somatrobol particularly useful during high-volume training phases or when managing joint wear from prior AAS cycles.
- Anti-catabolism: GH reduces protein catabolism during caloric restriction, allowing users to maintain lean mass while in deficit. At 1–3 IU/day, this is a central mechanism during body recomposition protocols.
- Sleep and recovery quality: Endogenous GH is secreted in pulses during slow-wave sleep. Exogenous GH often improves subjective sleep quality, recovery rate, and general well-being within 2–4 weeks of consistent use.
- Connective tissue and skin: Enhanced collagen and extracellular matrix production improves skin thickness and elasticity alongside tendon and cartilage integrity — a commonly cited benefit at anti-aging doses of 1–2 IU/day over 3+ months.
Who It's For
Somatrobol is suited for users running extended cycles (3 months minimum) where fat loss, recovery, and lean tissue retention are primary objectives. It does not produce the rapid strength or mass gains associated with anabolic-androgenic steroids and is not the right choice for users expecting visible results within a 4–8 week window.
The compound's primary differentiator from AAS is its action on connective tissue, fat partitioning, and IGF-1 production — combined with the absence of HPG-axis suppression. Users who train at high volume, experience joint issues, or are in sustained caloric deficit stand to gain the most. Peptide secretagogues (GHRP/GHRH) can stimulate endogenous GH release at lower cost, but their pulsatile output is unpredictable and dose-limited compared to exogenous rhGH.
Users who should choose an alternative: those targeting rapid hypertrophy or strength within a 6–8 week window should use Testabol Enanthate BD or Oxanabol BD instead. Somatrobol also requires a consistent multi-month commitment for meaningful body composition changes — users unable to sustain a 3+ month protocol are better served by shorter-cycle AAS options.
Somatrobol vs Alternatives
| Compound | Key Differences | Choose Somatrobol When | Choose Alternative When |
|---|---|---|---|
| Somatrobol BD (rhGH 100 IU) | Direct IGF-1 stimulation; lipolysis; collagen synthesis; no HPG suppression; requires 3+ months for meaningful results | Long cycle; fat loss + recovery + connective tissue support are priorities; anti-aging protocol | Short cycle (<8 weeks); rapid strength or mass is the primary goal; budget constraints |
| Stanabol Tabs BD (Stanozolol) | Oral AAS; vascularity + lean mass; SHBG reduction; no fat-specific or collagen mechanism; HPG suppression | 6–8 week cutting phase; lean mass and hardness without HGH commitment | Collagen support, IGF-1 effect, or multi-month recovery benefits are required |
| Primobol Inject BD (Methenolone Enanthate) | Mild injectable AAS; lean dry gains; low androgenic activity; HPG suppression; no fat-targeted mechanism | AAS-only lean cycle with minimal side effects; works well stacked with Somatrobol | Seeking a direct substitute for HGH effects — Primo does not replicate IGF-1 or collagen outputs |
| Oxanabol Tabs BD (Oxandrolone) | Ultra-mild oral; lean mass + strength; DHT-derived; no estrogenic activity; HPG suppression at full doses | Short oral-only lean cycle; female users; beginner protocols | Long-cycle body recomposition requiring fat loss, IGF-1, and connective tissue support |
Combinations
| Goal | Primary | Support Compounds | Notes |
|---|---|---|---|
| Fat loss / body recomp | Somatrobol BD 2–4 IU/day | Stanabol BD + T3 (thyroid hormone) | GH amplifies lipolysis; Stanozolol preserves lean mass; T3 counteracts GH-induced thyroid suppression on cycles longer than 16 weeks |
| Lean mass / performance | Somatrobol BD 3–6 IU/day | Testabol Enanthate BD + Primobol Inject BD + Anastrozole BD | Testosterone base + Primo for lean dry gains; Anastrozole controls E2 from testosterone; Somatrobol adds IGF-1 and connective tissue recovery layer |
| Anti-aging / recovery | Somatrobol BD 1–2 IU/day | Solo or + Testabol Enanthate BD (TRT dose) | Low-dose GH protocol; collagen and sleep benefits with minimal side effect risk; TRT optional for hormonal baseline support |
| Pre-contest | Somatrobol BD 2–4 IU/day | Mastabol 100 BD + Stanabol BD | Hardening + fat loss; manage GH dose to minimize water retention in peak week; Masteron controls E2 without an AI |
Side Effects & Management
| Side Effect | Frequency | How to Handle It |
|---|---|---|
| Water retention / edema | Very common (dose-dependent) | Reduce dose to 1–2 IU; limit dietary sodium; most resolves within 1–2 weeks of dose reduction; if blood pressure elevates, Amlip (amlodipine) supports BP management |
| Carpal tunnel syndrome | Common (especially >4 IU/day) | Reduce dose; wrist splints overnight; typically resolves fully upon discontinuation; avoid sustained high-dose use |
| Elevated fasting glucose / insulin resistance | Common on higher doses | Monitor fasting glucose monthly; keep doses ≤4 IU when possible; follow low-GI diet; Ecosprin (aspirin 75 mg/day) reduces cardiovascular risk associated with elevated glucose |
| Joint pain (arthralgia) | Common (early weeks) | Often dose-related; reduce dose for 1–2 weeks then titrate back up; typically improves as collagen synthesis accumulates over weeks 4–8 |
| Headaches | Occasional | Usually resolves within 2–4 weeks; reduce dose if persistent; check hydration and sodium balance |
| Hypothyroid-like symptoms | Less common (long cycles) | GH can suppress thyroid output on cycles beyond 16 weeks; monitor TSH, T3, T4; some users add low-dose T3 after bloodwork review |
| Injection site reactions / lipohypertrophy | Common with fixed sites | Rotate subcutaneous sites (abdomen, thighs, flanks); use proper aseptic technique; avoid injecting the same site repeatedly |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| IGF-1 | Baseline; at 4–6 weeks; every 3 months | Target mid-normal range for age; reduce dose if exceeding upper reference limit; primary GH response and dose-calibration marker |
| Fasting glucose | Baseline; monthly | <100 mg/dL; flag if >110 mg/dL — reduce dose and adjust diet; GH is anti-insulin and elevates fasting glucose at higher doses |
| HbA1c | Baseline; every 3 months | <5.7%; rising trend requires dose reduction and dietary intervention before proceeding |
| Fasting insulin | Baseline; every 3 months | <25 μIU/mL; elevated fasting insulin signals developing peripheral insulin resistance |
| Thyroid panel (TSH, T3, T4) | Baseline; every 3 months on cycles >16 weeks | Within normal reference range; subclinical hypothyroidism warrants T3 supplementation consideration |
| Lipid panel (HDL / LDL) | Baseline; every 3 months | HDL >40 mg/dL; LDL <130 mg/dL; GH at moderate doses has a neutral-to-favorable lipid profile |
| Blood pressure | Weekly (first month); monthly thereafter | <130/80 mmHg; fluid retention from GH can elevate BP; address with dose reduction and sodium restriction first |
PCT
Exogenous somatropin does not suppress the hypothalamic-pituitary-gonadal (HPG) axis. Somatrobol does not reduce LH, FSH, or endogenous testosterone production. No post-cycle therapy is required following a GH-only protocol.
Users running Somatrobol alongside anabolic-androgenic steroids should plan PCT based on the AAS compounds used. Standard protocols using Clomiphene BD and/or Tamoxifen BD apply to the AAS component only. GH can continue through PCT without interference — it does not affect HPTA recovery and may support lean mass retention during the post-cycle period.
Practical Summary
- Minimum cycle length: 3 months — fat loss and IGF-1-driven effects require sustained GH exposure; runs under 8 weeks produce minimal visible results.
- Dose by goal: 1–2 IU/day for anti-aging and recovery; 2–4 IU/day for fat loss and body recomp; 4–6 IU/day for performance cycles (split AM + PM).
- Injection timing: morning fasted for maximum lipolytic effect; or split AM + pre-sleep to approximate natural GH pulse patterns.
- Reconstitution and storage: use bacteriostatic water; refrigerate after mixing; use within 28 days; never freeze the reconstituted solution.
- Bloodwork checkpoints: IGF-1 at 4–6 weeks is the primary dose-calibration marker; fasting glucose monthly for insulin resistance monitoring on all doses above 2 IU/day.
- Glucose and cardiovascular support: Ecosprin 75 mg/day on cycles longer than 12 weeks as part of the cardiovascular monitoring protocol alongside regular glucose labs.
Somatrobol British Dragon remains one of the most consistently used rhGH options for athletes and experienced users targeting long-cycle fat loss, body recomposition, and connective tissue support. Unlike anabolic-androgenic steroids, it does not suppress the HPG axis, produces no estrogenic effects, and specifically addresses fat partitioning and collagen synthesis — areas AAS alone cannot cover. For best results, steroidwarehouse.com users pair Somatrobol at 2–4 IU/day with a testosterone base over 4–6 month cycles, adjusting dose based on IGF-1 response at weeks 4–6. The compound rewards patience: body composition, joint comfort, and recovery quality improve most noticeably from month two onward.
References
| Source | Topic | Link |
|---|---|---|
| Annals of Internal Medicine / PubMed | Liu H et al. 2007 — systematic review and meta-analysis evaluating the safety and efficacy of growth hormone therapy in healthy older adults; assessed body-composition changes and adverse effects across randomized controlled trials | Liu H, et al. (2007) ↗ |
| Journal of Clinical Endocrinology & Metabolism / PubMed | Molitch ME et al. 2011 — Endocrine Society clinical practice guideline on evaluation and treatment of adult growth hormone deficiency; covers diagnosis, GH replacement therapy, dosing, IGF-1 monitoring, adverse effects, contraindications, and follow-up | Molitch ME, et al. (2011) ↗ |
| New England Journal of Medicine / PubMed | Vance ML & Mauras N 1999 — review of growth hormone therapy in adults and children; covers GH physiology, IGF-1 mediation, approved clinical indications, metabolic effects, treatment considerations, and safety profile | Vance ML & Mauras N (1999) ↗ |
| Endotext / NCBI Bookshelf | Adult growth hormone deficiency clinical management — medical reference covering adult GHD diagnosis, GH replacement goals, clinical features, metabolic effects, treatment monitoring, IGF-1 targets, and safety considerations | Endotext: Adult Growth Hormone Deficiency ↗ |
What is Somatrobol?
Somatrobol is an injectable Human Growth Hormone (Somatropin) for muscle growth and fat loss; see What is Somatrobol. It's potent—consult professionals for safe use.
What does Somatrobol do?
It promotes muscle growth, fat loss, and recovery; see What Does Somatrobol Do. It enhances physique—monitor with labs.
How long does Somatrobol stay in your system?
Detectable for ~24-48 hours; see How Long Does Somatrobol Stay in Your System. Monitor with professional guidance.
How do I take Somatrobol?
2-4 IU/day, injected daily; see How to Take Somatrobol. Start low—consult professionals for dosing.
How to cycle Somatrobol?
3-6 months, 2-4 IU/day, no PCT needed; see How to Cycle Somatrobol. Stack with testosterone—consult professionals.
What are the main benefits of Somatrobol?
Commonly discussed benefits include improved recovery, support for lean muscle maintenance, enhanced body composition, increased tissue repair, and overall growth hormone support.
What are the possible side effects of Somatrobol?
Potential side effects may include fluid retention, joint discomfort, numbness or tingling sensations, headaches, and changes in glucose regulation depending on individual response.
What makes Somatrobol different from anabolic steroids?
Somatrobol contains growth hormone rather than anabolic steroids. It works primarily through growth hormone and IGF-1 pathways, whereas anabolic steroids act mainly through androgen receptors.
Related Products
- Promotes muscle growth and strength gains.
- Accelerates recovery from injuries and workouts.
- Enhances fat metabolism for a leaner physique.
- Improves skin elasticity and anti-aging effects.
- Maximizes muscle growth and strength gains.
- Accelerates recovery from injuries and workouts.
- Enhances fat metabolism for a leaner physique.
- Improves skin elasticity and anti-aging effects.
- Promotes lean muscle growth and strength.
- Enhances fat loss for a defined physique.
- Improves recovery and tissue repair.
- Supports anti-aging and overall vitality.